ZWITTERIONIC SILATRANE-BASED MATERIAL AND ANTIFOULING SUBSTRATE CONTAINING SAME
20200010489 · 2020-01-09
Inventors
Cpc classification
International classification
Abstract
The present invention provides a zwitterionic silatrane-based material and an antifouling substrate containing the same, wherein zwitterionic silatrane-based material has a structure as shown in Formula (I):
##STR00001##
Claims
1. A zwitterionic silatrane-based material comprising a structure as shown in Formula (I): ##STR00007## in which, Z.sup.t is R.sup.7SO.sub.3.sup., R.sup.7CO.sub.2.sup., R.sup.7OPO.sub.3.sup.2, R.sup.7PO.sub.3.sup.2 or R.sup.7OP(O)(R)O.sup.; structures of R, R.sup.1, R.sup.2, R.sup.3, and R.sup.7 are independently selected from a group consisting of aliphatic, aromatic, branched, linear, cyclic, and heterocyclic groups; R.sup.4, R.sup.5 and R.sup.6 are independently selected from a group consisting of methyl (Me), H, ethyl (Et), and CH.sub.2Cl.
2. The zwitterionic silatrane-based material according to claim 1, wherein Z.sup.t is R.sup.7SO.sub.3.sup..
3. The zwitterionic silatrane-based material according to claim 1, wherein R is an aliphatic series having 20 carbons or less.
4. The zwitterionic silatrane-based material according to claim 3, wherein R is methyl, ethyl, propyl or butyl.
5. The zwitterionic silatrane-based material according to claim 1, wherein R, R.sup.1, R.sup.2, R.sup.3, and R.sup.7 are independently selected from the group consisting of a C1-C20 alkyl group, a C2-C20 alkenyl group, and a C2-C20 alkynyl group.
6. The zwitterionic silatrane-based material according to claim 1, wherein R.sup.2 and R.sup.3 are the same.
7. The zwitterionic silatrane-based material according to claim 1, wherein R.sup.2 and R.sup.3 are different.
8. The zwitterionic silatrane-based material according to claim 1, wherein the zwitterionic silatrane-based material comprises a structure as shown in a Formula (II): ##STR00008##
9. An antifouling substrate, comprising: a base layer comprising a hydroxyl-containing surface; and a coating layer which is formed by coating the hydroxyl-containing surface of the base layer with a zwitterionic silatrane-based material, such that SiOSi bonds are formed between the zwitterionic silatrane-based material and the base layer and then SiOSi bonds are grafted onto the base layer in order; the zwitterionic silatrane-based material comprising a structure as shown in the Formula (I): ##STR00009## in which, Z.sup.t is R.sup.7SO.sub.3.sup., R.sup.7CO.sub.2.sup., R.sup.7OPO.sub.3.sup.2, R.sup.7PO.sub.3.sup.2 or R.sup.7OP(O)(R)O.sup.; the structures of R, R.sup.1, R.sup.2, R.sup.3, and R.sup.7 are independently selected from the group consisting of aliphatic, aromatic, branched, linear, cyclic, and heterocyclic groups; and R.sup.4, R.sup.5 and R.sup.6 are independently selected from the group consisting of methyl (Me), H, ethyl (Et), and CH.sub.2Cl.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
[0018]
[0019]
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0032] A zwitterionic material with a silatrane and an antifouling substrate formed by using the above material as a coating layer of the present invention are described below with reference to the drawings.
[0033] The zwitterionic silatrane-based material in the present invention comprises a structure as shown in a Formula (I):
##STR00005##
in which, Z.sup.t is R.sup.7SO.sub.3.sup., R.sup.7CO.sub.2.sup., R.sup.7OPO.sub.3.sup.2, R.sup.7PO.sub.3.sup.2 or R.sup.7OP(O)(R)O.sup.; structures of R, R.sup.1, R.sup.2, R.sup.3, and R.sup.7 are independently selected from a group consisting of aliphatic, aromatic, branched, linear, cyclic, and heterocyclic groups; R.sup.4, R.sup.5 and R.sup.6 are independently selected from a group consisting of methyl (Me), H, ethyl (Et), and CH.sub.2Cl.
[0034] In an embodiment, the present invention, Z.sup.t may be R.sup.7SO.sub.3.sup.; R may have 20 carbons or less, specifically may be an aliphatic series having 20 carbons or less, more specifically could be methyl, ethyl, propyl or butyl. In an embodiment of the present invention, R, R.sup.1, R.sup.2, R.sup.3, and R.sup.7 are independently selected from the group consisting of a C1-C20 alkyl group, a C2-C20 alkenyl group, and a C2-C20 alkynyl group.
[0035] In an embodiment of the present invention, R.sup.2 and R.sup.3 may be the same, for example, may be methyl. However, in other embodiments, R.sup.2 and R.sup.3 may also be different.
[0036] Synthesis of Zwitterionic Silatrane-Based Material
[0037] 22.8 mmol of (N,N-Dimethylaminopropyl)trimethoxysilane (DMASi) and 24.03 mmol of triethanolamine (TEOA) dissolved in methylbenzene are placed in a flask, and reacted under stirring at 110 C. for 30 hours reaction under a nitrogen atmosphere.
[0038] Next, the flask containing the above solution is kept at room temperature for 1 hour, and after adding sufficiently cooled n-pentane, the solutions are evaporated in vacuum to obtain a white precipitate. The white precipitate is washed with cooled n-pentane and collected by centrifugation at 9000 rpm for 5 minutes, and analyzed as (N,N-Dimethylaminopropyl) silatrane (DMASiT) with a yield of 66%.
[0039] 3.84 mmol of DMASiT and 3.84 mmol of 1,3-propanesultone are dissolved in 4 mL of anhydrous acetone to obtain a solution, and the solution is mixed and stirred for 6 hours at room temperature under nitrogen to react and obtain a white product. The white product is washed with anhydrous acetone and collected by centrifugation at 9000 rpm for 5 minutes. The white product is dried in vacuum to obtain zwitterionic sulfobetaine silatrane (SBSiT) with a yield of 83%.
[0040] The reaction formula is as follows:
##STR00006##
As a control, sulfobetaine silane (SBSi) is also synthesized here according to a conventional method. A preparation method of SBSi is as follows: 24 mmol of DMASi and 25 mmol of 1,3-propanesultone are dissolved in 25 ml of anhydrous acetone and stirred at room temperature for 6 hours under nitrogen. A white solid product on a filter after filtration of the above mixed solution is washed with acetone, and then dried in vacuum to obtain SBSi with a yield of 65%.
[0041] Chemical Stability Test
[0042] The dry solid powders of SBSi and SBSiT obtained above are placed in a laboratory environment (RH=79%, temperature=24 C.) for 24 hours, and the chemical stabilities of SBSi and SBSiT are examined by Fourier transform infrared spectroscopy (FTIR). Referring to
[0043] In order to compare the integrity of methoxyl and silylcyclopentane, signals of SBSiT from Vs(CH.sub.2)(2884 cm.sup.1) and Vas(CH.sub.2)(2948 cm.sup.1) as well as signals of SBSi from Vs(CH.sub.3)(2841 cm.sup.1) and Vas(CH.sub.2)(2959 cm.sup.1) are compared, and the results show that the spectra of SBSiT before storage for 24 hours (SBSiT As-prepared) and after storage for 24 hours (SBSiT 24 h-storage) are almost the same, while the absorption intensity of Vs(CH.sub.3) and Vas(CH.sub.2) of SBSi after storage for 24 hours (SBSi 24 h-storage) is significantly lower than that before storage for 24 hours (SBSi As-prepared).
[0044] Further referring to
[0045] Hydrophilicity Test
[0046] A substrate is sequentially washed in an ultrasonic treatment bath of 0.1% SDS, acetone, and ethanol for 10 minutes respectively, then dried in a nitrogen stream, and exposed the substrate to O.sub.2 plasma in a plasma cleaner (PDC-001, Harrick Plasma, NY) at a power of 10.5 W for 10 minutes twice to remove traces of contaminants from the surface for use as a base layer. Regarding the material of the substrate, such as a glass substrate, a silicon wafer, or the like, it may be used as the base layer of the present invention as long as it has a hydroxyl group, no matter it has a hydroxyl group itself or has a hydroxyl group obtained by other treatments.
[0047] The base layers are immersed in 5 mM of SBSiT or SBSi coating solution containing 10% by volume of H.sub.2O, and heated at 60 C. for 4.5 hours.
[0048] Next, the base layers are removed from the SBSiT or SBSi coating solution to form a coating layer on the base layers, then cleaned in an ultrasonic treatment bath of ethanol and dried in a nitrogen stream, and placed in an oven at 70 C. and baked for 1 hour. Since the base layers have a hydroxyl group, after the base layers are in contact with the SBSiT or SBSi coating solution, the coating solutions are hydrolyzed and condensed with the base layers to form SiOSi bonds, thereby obtaining an SBSiT antifouling substrate (Embodiment 1) and an SBSi anti-fouling substrate (Comparative Example 1).
[0049] According to the present embodiment, in order to accelerate the hydrolysis process, 2% acetic acid by volume is added to the coating solutions. It is found experimentally that, after a SBSiT solution containing 2% acetic acid by volume reacts with the 60 C. washed base layer to form a super-hydrophilic coating having a contact angle of <5 in 3-hour reaction (Embodiment 2 in
[0050] Due to the rapid hydrolysis of the silane group of SBSi in ethanol, SBSi is allowed to deposit rapidly on the glass, so the superhydrophilic coating can be obtained within 1 hour regardless of whether an acid is added. Please refer to groups of Comparative Example 1 in
[0051] In this experiment, the base layer (Control 1) which is not in contact with any coating solution, and the base layer (Control 2) which is in contact with acetic acid are compared with Comparative Example 1, Comparative Example 2, Embodiment 1, and Embodiment 2, see
[0052] It should be supplementarily noted that the above-mentioned acid is found to increase the hydrolysis rate of silatrane. Please refer to
[0053] Further, for convenience of description, the controls, the comparative examples, and the embodiments described in the following series of experimental tests are defined as shown in Table 1 below.
TABLE-US-00001 TABLE 1 Definition Control 1 The base layer that is not in contact with any coating solution Control 2 The base layer treated with an acidic solution Comparative The base layer treated with SBSi Example 1 Comparative The base layer treated with SBSi containing an acidic Example 2 solution Embodiment 1 The base layer treated with SBSiT Embodiment 2 The base layer treated with SBSiT containing an acidic solution
[0054] Flatness Test
[0055] In order to test the flatness of the anti-fouling substrates, an atomic force microscope (AFM) and an ellipsometry are used to study the surface morphology and thickness of the coating layer in each anti-fouling substrate in Table 1.
[0056] First, the AFM results show that the coating layer in Embodiment 2 is almost as flat as the above-mentioned Control 1 that is not in contact with any coating solution, and the root mean square (RMS) roughness (Rq) values thereof are 4.4 and 5.4, respectively, thereby showing that the SBSiT coating layer has good uniformity. Slow hydrolysis of the silatranyl groups causes the SBSiT molecules to be grafted onto a surface of the base layer in order, by forming SiOSi bonds with the base layer.
[0057] However, abundant microparticles appear on the surfaces of Comparative Example 1 and Comparative Example 2 treated with the SBSi coating solution containing acetic acid or containing no acetic acid.
[0058] Further, the thickness of the coating layer of each of the antifouling substrates is measured by ellipsometry. Referring to
[0059] Cytotoxicity Test
[0060] In order to test the potential of antifouling coatings applied in the field of biomedical engineering, cytotoxicity tests are performed on the previously synthesized SBSi and SBSiT.
[0061] SBSi, SBSiT and 1,3-propanesultone (as a toxic comparative) are dissolved in a medium at a concentration of 0.2 to 25 mM, respectively. After incubation of the above medium with NIH-3T3 fibroblasts for 24 hours, the cell activity is detected by cell viability performing analysis on (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide MTT).
[0062] As shown in
[0063] Antibacterial Test Grain-negative Escherichia coli (E. coli) and Gram-positive Staphylococcus epidermidis (S. epidermidis) are treated to the anti-fouling substrate of Table 1 for 4.5 hours, and live/dead bacteria adhered on the coatings are calibrated with fluorescent dye, and therefore, the degree of bacterial contamination is detected.
[0064] Please refer to
[0065] Embodiment 1 (SBSiT w/o acid) and Embodiment 2 (SBSiT w/ acid) each have a better antibacterial effect than Control 1, and especially the anti-fouling substrate of Embodiment 2 (SBSiT w/ acid) can resist bacterial contamination and can achieve an effect similar to that of SBSi anti-fouling substrate.
[0066] Structural Stability Test
[0067] In this experiment, a multifunctional high-precision quartz microbalance QCM-D is used to simultaneously evaluate the viscoelastic properties of the adsorbed wet matter and the coating. The bovine serum albumin (BSA) protein solution prepared at a concentration of 1 mg/mL in the phosphate buffered saline (PBS) flows through the surface of each of the antifouling substrates in Table 1, and the frequency change (f) and the dispersion change (D) of QCM are recorded.
[0068] As shown in
[0069] The dissipation change (D) is used to measure the properties of the coating associated with viscoelasticity. In
[0070] The zwitterionic silatrane-based material of the present invention comprises a tricyclic caged silatranyl ring and transannular N.fwdarw.Si dative bond, thereby forming a strong antifouling coating, which not only breaks through the problem of surface aggregation and unevenness caused by easy hydrolysis of silane functional groups, but also maintains the property of good anti-non-specific adsorption of amphoteric double ions, and has a great potential as an amphoteric double-ion anti-fouling coating. Furthermore, the zwitterionic silatrane-based material of the present invention can resist adsorption of bacteria and proteins after testing, and has good structural stability after QCM-D testing, and is of a major development in the field of biomedical engineering.